Recurrent ischemic cerebrovascular events in a patient with type i antithrombin deficiency caused by 9788 G>A splice site mutation: A case report

Blood Coagulation and Fibrinolysis

Volumn 24, Issue 2, 2013, Pages 213-215

  Szymańska, Magdalena ^a   Alhenc Gelas, Martine ^b   Undas, Anetta ^a,c  

^a Krakowski Szpital Specjalistyczny Im Jana Pawła II   (Poland)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^c JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

antithrombin deficiency; cerebrovascular ischemic events; SERPINC1 mutation; thromboembolism

Indexed keywords

ACETYLSALICYLIC ACID; ENOXAPARIN; NUCLEOTIDE; WARFARIN;

ADULT; ANTITHROMBIN DEFICIENCY; ARTERY THROMBOSIS; ARTICLE; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CASE REPORT; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; DNA SEQUENCE; FOLLOW UP; GENE MUTATION; HEMIPARESIS; HETEROZYGOSITY; HUMAN; LEG THROMBOSIS; MALE; PRIORITY JOURNAL; TRANSIENT ISCHEMIC ATTACK; VENOUS THROMBOEMBOLISM;

ADULT; ANTITHROMBIN III DEFICIENCY; FIBRIN; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; MUTATION; RISK FACTORS; RNA SPLICE SITES;

EID: 84873363156     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0b013e32835b2467     Document Type: Article

References (16)

1. Patnaik MM, Moll S. Inherited antithrombin deficiency: A review. Haemophilia 2008; 14:1229-1239
2. De Stefano V, Simioni P, Rossi E, Tormene D, Za T, Pagnan A, Leone G. The risk of recurrent venous thromboembolism in patients with inherited deficiency of natural anticoagulants antithrombin, protein C and protein S. Haematologica 2006; 91:695-698
3. Martinez HR, Rangel-Guerra RA, Marfil LJ. Ischemic stroke due to deficiency of coagulation inhibitors. Report of 10 young adults. Stroke 1993; 24:19-25
4. Perry DJ, Carrell RW. Molecular genetics of human antithrombin deficiency. Hum Mutat 1996; 7:7-22
5. Kenet G, Lütkhoff LK, Albisetti M, Bernard T, Bonduel M, Brandao L, et al. Impact of thrombophilia on risk of arterial ischemic stroke or cerebral sinovenous thrombosis in neonates and children: A systematic review and meta-Analysis of observational studies. Circulation 2010; 121:1838-1847
6. Linnemann B, Schindewolf M, Zgouras D, Erbe M, Jarosch-Preusche M, Lindhoff-Last E. Are patients with thrombophilia and previous venous thromboembolism at higher risk to arterial thrombosis? Thromb Res 2008; 121:743-750
7. Hankey GJ, Eikelboom JW, van Bockxmeer FM, Lofthouse E, Staples N, Baker RI. Inherited thrombophilia in ischemic stroke and its pathogenic subtypes. Stroke 2001; 32:1793-1799
8. Rolda'n V, Ordoñez A, Mari'n F, Zorio E, Soria JM, Miñano A, et al. Antithrombin Cambridge II (A384S) supports a role for antithrombin deficiency in arterial thrombosis. Thromb Haemost 2009; 101:483-486
9. Olds RJ, Lane DA, Chowdhury V, De Stefano V, Leone G, Thein SL. Complete nucleotide sequence of the antithrombin gene: Evidence for homologous recombination causing thrombophilia. Biochemistry 1993; 32:4216-4224
10. Picard V, Nowak-Göttl U, Biron-Andreani C, Fouassier M, Frere C, Goualt-Heilman M, et al. Molecular bases of antithrombin deficiency: Twenty-Two novel mutations in the antithrombin gene. Hum Mutat 2006; 27:600
11. Celinska-Lowenhoff M, Iwaniec T, Alhenc-Gelas M, Musial J, Undas A. Arterial and venous thrombosis and prothrombotic fibrin clot phenotype in a Polish family with type 1 antithrombin deficiency (antithrombin Krakow). Thromb Haemost 2011; 106:379-381
12. Celinska-Löwenhoff M, Iwaniec T, Alhenc-Gelas M, Musial J, Undas A. Antithrombin Krakow II (c.6241 G > T): A novel mutation leading to type 1 antithrombin deficiency. Blood Coagul Fibrinolysis 2012; 23:454-455
13. Jochmans K, Lissens W, Yin T, Michiels JJ, van der Luit L, Peerlinck K, et al. Molecular basis for type 1 antithrombin deficiency: Identification of two novel point mutations and evidence for a de novo splice site mutation. Blood 1994; 84:3742-3748
14. Emmerich J, Vidaud D, Alhenc-Gelas M, Chadeuf G, Gouault-Heilmann M, Aillaud MF, et al. Three novel mutations of antithrombin inducing highmolecular-mass compounds. Arterioscler Thromb 1994; 14:1958-1965
15. David D, Ribeiro S, Ferräo L, Gago T, Crespo F. Molecular basis of inherited antithrombin deficiency in Portuguese families: Identification of genetic alterations and screening for additional thrombotic risk factors. Am J Hematol 2004; 76:163-171
16. Stief TW. Inhibition of thrombin generation in recalcified plasma. Blood Coagul Fibrinolysis 2007; 18:751-760